JP2004504323A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504323A5
JP2004504323A5 JP2002512186A JP2002512186A JP2004504323A5 JP 2004504323 A5 JP2004504323 A5 JP 2004504323A5 JP 2002512186 A JP2002512186 A JP 2002512186A JP 2002512186 A JP2002512186 A JP 2002512186A JP 2004504323 A5 JP2004504323 A5 JP 2004504323A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
acid addition
free base
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002512186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504323A (ja
JP3939246B2 (ja
Filing date
Publication date
Priority claimed from GBGB0017508.3A external-priority patent/GB0017508D0/en
Application filed filed Critical
Publication of JP2004504323A publication Critical patent/JP2004504323A/ja
Publication of JP2004504323A5 publication Critical patent/JP2004504323A5/ja
Application granted granted Critical
Publication of JP3939246B2 publication Critical patent/JP3939246B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002512186A 2000-07-17 2001-07-16 インドロキナゾリノン類 Expired - Fee Related JP3939246B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017508.3A GB0017508D0 (en) 2000-07-17 2000-07-17 Antimicrobials
PCT/EP2001/008192 WO2002006284A1 (en) 2000-07-17 2001-07-16 Indoloquinazolinones

Publications (3)

Publication Number Publication Date
JP2004504323A JP2004504323A (ja) 2004-02-12
JP2004504323A5 true JP2004504323A5 (enExample) 2005-02-03
JP3939246B2 JP3939246B2 (ja) 2007-07-04

Family

ID=9895801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512186A Expired - Fee Related JP3939246B2 (ja) 2000-07-17 2001-07-16 インドロキナゾリノン類

Country Status (18)

Country Link
US (1) US6964960B2 (enExample)
EP (1) EP1303517B1 (enExample)
JP (1) JP3939246B2 (enExample)
CN (1) CN1183136C (enExample)
AR (1) AR031379A1 (enExample)
AT (1) ATE262530T1 (enExample)
AU (1) AU2001279754A1 (enExample)
BR (1) BR0112521A (enExample)
CA (1) CA2415683C (enExample)
DE (1) DE60102473T2 (enExample)
DK (1) DK1303517T3 (enExample)
ES (1) ES2218439T3 (enExample)
GB (1) GB0017508D0 (enExample)
MY (1) MY133969A (enExample)
PE (1) PE20020210A1 (enExample)
PT (1) PT1303517E (enExample)
TR (1) TR200401026T4 (enExample)
WO (1) WO2002006284A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956035B2 (en) 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
AU2004258801A1 (en) 2003-02-28 2005-02-03 Inotek Pharmaceuticals Corporation Tetracyclic Benzamide Derivatives and methods of use thereof
EP1855676A4 (en) 2005-02-25 2008-05-21 Inotek Pharmaceuticals Corp TETRAZYCLIC AMINO AND CARBOXAMIDE COMPOUNDS AND METHOD FOR THEIR USE
AU2006283078A1 (en) 2005-08-24 2007-03-01 Inotek Pharmaceuticals Corporation Indenoisoquinolinone Analogs and methods of use thereof
ES2559679T3 (es) * 2006-06-20 2016-02-15 Abbvie Inc. Pirazoloquinazolinonas como inhibidores de PARP
GB0615809D0 (en) * 2006-08-09 2006-09-20 Istituto Di Ricerche D Biolog Therapeutic compounds
GB0701273D0 (en) * 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
US8119654B2 (en) 2007-02-28 2012-02-21 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
EP2409700A1 (en) 2007-05-08 2012-01-25 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
ES2562903T3 (es) * 2011-07-13 2016-03-09 Santen Pharmaceutical Co., Ltd Nuevo compuesto que tiene actividad inhibidora de PARP
CN102766144B (zh) * 2012-07-10 2014-04-23 浙江大学 一种吲哚并[1,2-c]喹唑啉化合物的制备方法
ES2879434T3 (es) 2015-07-23 2021-11-22 Inst Curie Uso de una combinación de molécula Dbait e inhibidores de PARP para tratamiento del cáncer
GB201519573D0 (en) 2015-11-05 2015-12-23 King S College London Combination
WO2018162439A1 (en) 2017-03-08 2018-09-13 Onxeo New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule
US20200407720A1 (en) 2018-03-13 2020-12-31 Onxeo A dbait molecule against acquired resistance in the treatment of cancer
KR20210097733A (ko) * 2018-11-30 2021-08-09 메르크 파텐트 게엠베하 전자 디바이스용 화합물
EP3938367A1 (de) * 2019-03-12 2022-01-19 Merck Patent GmbH Materialien für organische elektrolumineszenzvorrichtungen
CN110357892B (zh) * 2019-07-10 2022-06-07 云南大学 四氢嘧啶并[1,2-a]吲哚衍生物及其合成方法与应用
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
CN114195789B (zh) * 2021-12-15 2022-09-09 广东海洋大学 一种无金属参与的多环吲哚衍生物的制备方法
CN121398822A (zh) 2023-06-21 2026-01-23 四方生物科学有限公司 用于在治疗hr功能正常的癌症的方法中的用途的包含脱氧胞苷衍生物和parp抑制剂的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635966A (en) 1969-10-22 1972-01-18 Robins Co Inc A H 6-substituted-indolo(1 2-c)quinazolines
DE2237372C3 (de) 1972-07-29 1981-07-09 Basf Ag, 6700 Ludwigshafen Heterocyclische Farbstoffe, ihre Herstellung und ihre Verwendung
US5441955A (en) * 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues

Similar Documents

Publication Publication Date Title
JP2004504323A5 (enExample)
JP2001525322A5 (enExample)
CA2415683A1 (en) Indoloquinazolinones
JP2009542613A5 (enExample)
JP2007501809A5 (enExample)
JP2005533804A5 (enExample)
CA2485641A1 (en) Novel condensed imidazole derivatives
JP2005500988A5 (enExample)
CY1116082T1 (el) Μεθοδος παρασκευης ενωσεων βενζαζεπινης ή αλατων τους
JP2005053931A5 (enExample)
JP2005502658A5 (enExample)
EP1562949A4 (en) METHOD FOR PRODUCING PYRROLOTRIAZIN COMPOUNDS SUITABLE AS KINASEINHIBITORS
JP2001510843A5 (enExample)
JP2003503449A5 (enExample)
EP1857459A3 (en) Pyrazolopyrimidine compound and a process for preparing the same
CA2527496A1 (en) 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
JP2004529953A5 (enExample)
JP2002506864A5 (enExample)
JP2006515600A5 (enExample)
JP2005514332A5 (enExample)
JP2004525178A5 (enExample)
JP2006518765A5 (enExample)
JP2006514956A5 (enExample)
JP2004538278A5 (enExample)
JP2005517016A5 (enExample)